Life360, Inc.·4

Mar 17, 4:43 PM ET

Wiadrowski David 4

4 · Life360, Inc. · Filed Mar 17, 2026

Research Summary

AI-generated summary of this filing

Updated

Life360 Director David Wiadrowski Exercises Options, Sells Shares

What Happened
David Wiadrowski, a director of Life360 (LIF), exercised stock options on March 13, 2026 and sold some shares. He exercised a total of 21,310 option shares (13,850 at $13.35 — $184,898; and 7,460 at $8.19 — $61,097). He sold 5,957 shares in the open market at a weighted-average price of $41.34, generating proceeds of $246,262. The filing indicates the exercise was done on a cashless basis and the market sale was used solely to cover the option exercise cost.

Key Details

  • Transaction date: March 13, 2026 (Form filed March 17, 2026).
  • Option exercises (code M): 13,850 shares @ $13.35 (acquired, $184,898) and 7,460 shares @ $8.19 (acquired, $61,097).
  • Sales (code S): 5,957 shares sold in the open market at a weighted-average price of $41.34 (proceeds $246,262). Reported sale prices ranged $41.27–$41.455 per share.
  • Additional disposals at $0 reflect shares surrendered in the cashless exercise (derivative disposition).
  • Filing notes: F1 — cashless exercise; F3 — shares sold solely to cover exercise cost; F4 — weighted-average sale price and per-share range; F5 — the options were fully vested and exercisable; F2 — filing references 738 restricted stock units (contingent shares).
  • Shares owned after the transaction are not specified in the provided extract.

Context

  • This was an option exercise with a cashless/covering sale rather than a straightforward purchase. Cashless exercises often involve surrendering or selling enough shares to cover exercise price and taxes; here the open-market sale was identified as covering the exercise cost.
  • The sale to cover exercise costs is generally considered routine and does not necessarily signal bullish or bearish views by the insider.
  • The Form 4 was filed four days after the reported transactions (filed Mar 17 for Mar 13 trades); Form 4s are typically due within two business days, so reviewers may note the filing timing.

Insider Transaction Report

Form 4
Period: 2026-03-13
Transactions
  • Exercise/Conversion

    Common Stock

    [F1][F2]
    2026-03-13$13.35/sh+13,850$184,89838,176 total
  • Exercise/Conversion

    Common Stock

    [F1][F2]
    2026-03-13$8.19/sh+7,460$61,09745,636 total
  • Sale

    Common Stock

    [F3][F4][F2]
    2026-03-13$41.34/sh5,957$246,26239,679 total
  • Exercise/Conversion

    Stock Option (right to buy)

    [F1][F5]
    2026-03-1313,8500 total
    Exercise: $13.35Exp: 2027-04-29Common stock (13,850 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    [F1][F5]
    2026-03-137,46016,051 total
    Exercise: $8.19Exp: 2028-05-20Common stock (7,460 underlying)
Footnotes (5)
  • [F1]The reporting person exercised the stock options on a cashless basis.
  • [F2]Includes 738 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  • [F3]Shares of the Issuer's common stock were sold in the open market solely to cover the option exercise cost.
  • [F4]The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $41.27 to $41.455, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
  • [F5]The stock option is fully vested and exercisable.
Signature
/s/ Jay Sood, Attorney-in-Fact|2026-03-17

Documents

1 file
  • 4
    wk-form4_1773780182.xmlPrimary

    FORM 4